APO Research
Talk to an analyst

APO RESEARCH · REPORT

Surface Protein gp120

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Surface Protein gp120 Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchSurface Protein gp120 Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Surface Protein gp120 Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Surface Protein gp120 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Surface Protein gp120 Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Surface Protein gp120 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Surface Protein gp120 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Surface Protein gp120 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Surface Protein gp120 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Surface Protein gp120 market include Sanofi Pasteur SA, GlaxoSmithKline Plc, ViiV Healthcare Limited, United Biomedical, Inc., TeneoBio Inc and Osel, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Surface Protein gp120 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Surface Protein gp120 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Surface Protein gp120 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Surface Protein gp120 market size, projected growth trends, production technologies, key applications, and end-use industries.

Surface Protein gp120 Segment by Company

Sanofi Pasteur SA

GlaxoSmithKline Plc

ViiV Healthcare Limited

United Biomedical, Inc.

TeneoBio Inc

Osel, Inc.

Surface Protein gp120 Segment by Type

BMD-104

DS-003

HNG-156

M-48U1

Others

Surface Protein gp120 Segment by Application

Hospital

Clinic

Others

Surface Protein gp120 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Surface Protein gp120 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Surface Protein gp120 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Surface Protein gp120 significant trends, drivers, influence factors in global and regions.

6. To analyze Surface Protein gp120 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surface Protein gp120 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Surface Protein gp120 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surface Protein gp120.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Surface Protein gp120 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Surface Protein gp120 industry.

Chapter 3: Detailed analysis of Surface Protein gp120 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Surface Protein gp120 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Surface Protein gp120 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Surface Protein gp120 Industry Trends Table 2. Surface Protein gp120 Industry Drivers Table 3. Surface Protein gp120 Industry Opportunities and Challenges Table 4. Surface Protein gp120 Industry Restraints Table 5. Global Surface Protein gp120 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Surface Protein gp120 Revenue Share by Company (2021-2026) Table 7. Global Surface Protein gp120 Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Surface Protein gp120 Sales Volume Share by Company (2021-2026) Table 9. Global Surface Protein gp120 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Surface Protein gp120 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Surface Protein gp120 Key Company Manufacturing Base & Headquarters Table 12. Global Surface Protein gp120 Company, Product Type & Application Table 13. Global Surface Protein gp120 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Surface Protein gp120 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of BMD-104 Table 18. Significant Companies of DS-003 Table 19. Significant Companies of HNG-156 Table 20. Significant Companies of M-48U1 Table 21. Significant Companies of Others Table 22. Global Surface Protein gp120 Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Surface Protein gp120 Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Surface Protein gp120 Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Surface Protein gp120 Sales Volume Share by Type (2021-2026) Table 26. Global Surface Protein gp120 Sales Volume Share by Type (2027-2032) Table 27. Global Surface Protein gp120 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Surface Protein gp120 Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Surface Protein gp120 Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Surface Protein gp120 Sales Value Share by Type (2021-2026) Table 31. Global Surface Protein gp120 Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Surface Protein gp120 Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Surface Protein gp120 Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Surface Protein gp120 Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Surface Protein gp120 Sales Volume Share by Application (2021-2026) Table 39. Global Surface Protein gp120 Sales Volume Share by Application (2027-2032) Table 40. Global Surface Protein gp120 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Surface Protein gp120 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Surface Protein gp120 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Surface Protein gp120 Sales Value Share by Application (2021-2026) Table 44. Global Surface Protein gp120 Sales Value Share by Application (2027-2032) Table 45. Global Surface Protein gp120 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Surface Protein gp120 Sales by Region (2021-2026) & (K Units) Table 47. Global Surface Protein gp120 Sales Market Share by Region (2021-2026) Table 48. Global Surface Protein gp120 Sales by Region (2027-2032) & (K Units) Table 49. Global Surface Protein gp120 Sales Market Share by Region (2027-2032) Table 50. Global Surface Protein gp120 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Surface Protein gp120 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Surface Protein gp120 Sales Value Share by Region (2021-2026) Table 53. Global Surface Protein gp120 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Surface Protein gp120 Sales Value Share by Region (2027-2032) Table 55. Global Surface Protein gp120 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Surface Protein gp120 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Surface Protein gp120 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Surface Protein gp120 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Surface Protein gp120 Sales by Country (2021-2026) & (K Units) Table 60. Global Surface Protein gp120 Sales Market Share by Country (2021-2026) Table 61. Global Surface Protein gp120 Sales by Country (2027-2032) & (K Units) Table 62. Global Surface Protein gp120 Sales Market Share by Country (2027-2032) Table 63. Global Surface Protein gp120 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Surface Protein gp120 Sales Value Market Share by Country (2021-2026) Table 65. Global Surface Protein gp120 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Surface Protein gp120 Sales Value Market Share by Country (2027-2032) Table 67. Sanofi Pasteur SA Company Information Table 68. Sanofi Pasteur SA Business Overview Table 69. Sanofi Pasteur SA Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sanofi Pasteur SA Surface Protein gp120 Product Portfolio Table 71. Sanofi Pasteur SA Recent Development Table 72. GlaxoSmithKline Plc Company Information Table 73. GlaxoSmithKline Plc Business Overview Table 74. GlaxoSmithKline Plc Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Plc Surface Protein gp120 Product Portfolio Table 76. GlaxoSmithKline Plc Recent Development Table 77. ViiV Healthcare Limited Company Information Table 78. ViiV Healthcare Limited Business Overview Table 79. ViiV Healthcare Limited Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. ViiV Healthcare Limited Surface Protein gp120 Product Portfolio Table 81. ViiV Healthcare Limited Recent Development Table 82. United Biomedical, Inc. Company Information Table 83. United Biomedical, Inc. Business Overview Table 84. United Biomedical, Inc. Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. United Biomedical, Inc. Surface Protein gp120 Product Portfolio Table 86. United Biomedical, Inc. Recent Development Table 87. TeneoBio Inc Company Information Table 88. TeneoBio Inc Business Overview Table 89. TeneoBio Inc Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. TeneoBio Inc Surface Protein gp120 Product Portfolio Table 91. TeneoBio Inc Recent Development Table 92. Osel, Inc. Company Information Table 93. Osel, Inc. Business Overview Table 94. Osel, Inc. Surface Protein gp120 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Osel, Inc. Surface Protein gp120 Product Portfolio Table 96. Osel, Inc. Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Surface Protein gp120 Distributors List Table 100. Surface Protein gp120 Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Surface Protein gp120 Product Image Figure 2. Global Surface Protein gp120 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Surface Protein gp120 Sales (2021-2032) & (K Units) Figure 5. Global Surface Protein gp120 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Surface Protein gp120 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. BMD-104 Image Figure 10. DS-003 Image Figure 11. HNG-156 Image Figure 12. M-48U1 Image Figure 13. Others Image Figure 14. Global Surface Protein gp120 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Surface Protein gp120 Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Surface Protein gp120 Sales Volume Share by Type (2021-2032) Figure 17. Global Surface Protein gp120 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Surface Protein gp120 Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Surface Protein gp120 Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Surface Protein gp120 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Surface Protein gp120 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Surface Protein gp120 Sales Volume Share by Application (2021-2032) Figure 26. Global Surface Protein gp120 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Surface Protein gp120 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Surface Protein gp120 Sales Value Share by Application (2021-2032) Figure 29. Global Surface Protein gp120 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Surface Protein gp120 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Surface Protein gp120 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Surface Protein gp120 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Surface Protein gp120 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Surface Protein gp120 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Surface Protein gp120 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Surface Protein gp120 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Surface Protein gp120 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Surface Protein gp120 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Surface Protein gp120 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Surface Protein gp120 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Surface Protein gp120 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • BMD-104
  • DS-003
  • HNG-156
  • M-48U1
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi Pasteur SA
  • GlaxoSmithKline Plc
  • ViiV Healthcare Limited
  • United Biomedical, Inc.
  • TeneoBio Inc
  • Osel, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Surface Protein gp120 Sales Value (2021-2032)
  4. 1.2.2 Global Surface Protein gp120 Sales Volume (2021-2032)
  5. 1.2.3 Global Surface Protein gp120 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Surface Protein gp120 Market Dynamics
  1. 2.1 Surface Protein gp120 Industry Trends
  2. 2.2 Surface Protein gp120 Industry Drivers
  3. 2.3 Surface Protein gp120 Industry Opportunities and Challenges
  4. 2.4 Surface Protein gp120 Industry Restraints
3 Surface Protein gp120 Market by Company
  1. 3.1 Global Surface Protein gp120 Company Revenue Ranking in 2025
  2. 3.2 Global Surface Protein gp120 Revenue by Company (2021-2026)
  3. 3.3 Global Surface Protein gp120 Sales Volume by Company (2021-2026)
  4. 3.4 Global Surface Protein gp120 Average Price by Company (2021-2026)
  5. 3.5 Global Surface Protein gp120 Company Ranking (2024-2026)
  6. 3.6 Global Surface Protein gp120 Company Manufacturing Base and Headquarters
  7. 3.7 Global Surface Protein gp120 Company Product Type and Application
  8. 3.8 Global Surface Protein gp120 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Surface Protein gp120 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Surface Protein gp120 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Surface Protein gp120 Market by Type
  1. 4.1 Surface Protein gp120 Type Introduction
  2. 4.1.1 BMD-104
  3. 4.1.2 DS-003
  4. 4.1.3 HNG-156
  5. 4.1.4 M-48U1
  6. 4.1.5 Others
  7. 4.2 Global Surface Protein gp120 Sales Volume by Type
  8. 4.2.1 Global Surface Protein gp120 Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Surface Protein gp120 Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Surface Protein gp120 Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Surface Protein gp120 Sales Value by Type
  12. 4.3.1 Global Surface Protein gp120 Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Surface Protein gp120 Sales Value by Type (2021-2032)
  14. 4.3.3 Global Surface Protein gp120 Sales Value Share by Type (2021-2032)
5 Surface Protein gp120 Market by Application
  1. 5.1 Surface Protein gp120 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Surface Protein gp120 Sales Volume by Application
  6. 5.2.1 Global Surface Protein gp120 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Surface Protein gp120 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Surface Protein gp120 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Surface Protein gp120 Sales Value by Application
  10. 5.3.1 Global Surface Protein gp120 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Surface Protein gp120 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Surface Protein gp120 Sales Value Share by Application (2021-2032)
6 Surface Protein gp120 Regional Sales and Value Analysis
  1. 6.1 Global Surface Protein gp120 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Surface Protein gp120 Sales by Region (2021-2032)
  3. 6.2.1 Global Surface Protein gp120 Sales by Region: 2021-2026
  4. 6.2.2 Global Surface Protein gp120 Sales by Region (2027-2032)
  5. 6.3 Global Surface Protein gp120 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Surface Protein gp120 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Surface Protein gp120 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Surface Protein gp120 Sales Value by Region (2027-2032)
  9. 6.5 Global Surface Protein gp120 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Surface Protein gp120 Sales Value (2021-2032)
  12. 6.6.2 North America Surface Protein gp120 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Surface Protein gp120 Sales Value (2021-2032)
  15. 6.7.2 Europe Surface Protein gp120 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Surface Protein gp120 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Surface Protein gp120 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Surface Protein gp120 Sales Value (2021-2032)
  21. 6.9.2 South America Surface Protein gp120 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Surface Protein gp120 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Surface Protein gp120 Sales Value Share by Country, 2025 VS 2032
7 Surface Protein gp120 Country-level Sales and Value Analysis
  1. 7.1 Global Surface Protein gp120 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Surface Protein gp120 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Surface Protein gp120 Sales by Country (2021-2032)
  4. 7.3.1 Global Surface Protein gp120 Sales by Country (2021-2026)
  5. 7.3.2 Global Surface Protein gp120 Sales by Country (2027-2032)
  6. 7.4 Global Surface Protein gp120 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Surface Protein gp120 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Surface Protein gp120 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Surface Protein gp120 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Surface Protein gp120 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Surface Protein gp120 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur SA
  2. 8.1.1 Sanofi Pasteur SA Company Information
  3. 8.1.2 Sanofi Pasteur SA Business Overview
  4. 8.1.3 Sanofi Pasteur SA Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur SA Surface Protein gp120 Product Portfolio
  6. 8.1.5 Sanofi Pasteur SA Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Surface Protein gp120 Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 ViiV Healthcare Limited
  14. 8.3.1 ViiV Healthcare Limited Company Information
  15. 8.3.2 ViiV Healthcare Limited Business Overview
  16. 8.3.3 ViiV Healthcare Limited Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ViiV Healthcare Limited Surface Protein gp120 Product Portfolio
  18. 8.3.5 ViiV Healthcare Limited Recent Developments
  19. 8.4 United Biomedical, Inc.
  20. 8.4.1 United Biomedical, Inc. Company Information
  21. 8.4.2 United Biomedical, Inc. Business Overview
  22. 8.4.3 United Biomedical, Inc. Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 United Biomedical, Inc. Surface Protein gp120 Product Portfolio
  24. 8.4.5 United Biomedical, Inc. Recent Developments
  25. 8.5 TeneoBio Inc
  26. 8.5.1 TeneoBio Inc Company Information
  27. 8.5.2 TeneoBio Inc Business Overview
  28. 8.5.3 TeneoBio Inc Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TeneoBio Inc Surface Protein gp120 Product Portfolio
  30. 8.5.5 TeneoBio Inc Recent Developments
  31. 8.6 Osel, Inc.
  32. 8.6.1 Osel, Inc. Company Information
  33. 8.6.2 Osel, Inc. Business Overview
  34. 8.6.3 Osel, Inc. Surface Protein gp120 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Osel, Inc. Surface Protein gp120 Product Portfolio
  36. 8.6.5 Osel, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Surface Protein gp120 Value Chain Analysis
  2. 9.1.1 Surface Protein gp120 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Surface Protein gp120 Sales Mode & Process
  6. 9.2 Surface Protein gp120 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Surface Protein gp120 Distributors
  9. 9.2.3 Surface Protein gp120 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst